Sort
82,697 grants matching “vaccine development”
Development of a Replicon RNA-based Vaccine against Dengue and Zika
$721,849Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2024 · AI
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
$721,846Theresa L Chang · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support and Concept and Protocol Development, Implementation and Assays for a Phase I Rabies Virus Vaccine Trial
$721,834Mark Joseph Mulligan · Emory University · N01 · FY2019 · AI
Structural and functional basis of ultra potent CHKV neutralization by human mAbs
$721,808James E Crowe · Vanderbilt University Medical Center · R01 · FY2019 · AI
Syrian hamsters as an animal model for influenza virus research
$721,773Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2020 · AI
Marburg Vaccine Development
$721,751Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates
$721,736Thomas A Ficht · University Of Texas Med Br Galveston · U54 · FY2009 · AI
MUC16 Antibody Based Strategies for Imaging and Therapy
$721,721David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Rochester Roybal Center for Social Ties and Aging Research
$721,713Kathi L Heffner · University Of Rochester · P30 · FY2019 · AG
Development and Testing of New Tuberculosis Vaccines
$721,686Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2010 · AI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
$721,615J Brooks Jackson · Social And Scientific Systems, Inc. · U01 · FY2010 · AI
Role of Innate Immunity in Controlling HIV Infection
$721,499Jay A Levy · University Of California, San Francisco · R01 · FY2010 · AI
Guinea pig model for TB vaccine evaluations
$721,424Colorado State University-Fort Collins · R01 · FY2005 · AI
Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring
$721,393Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2023 · HD
ZIMBABWE--COMMUNITY INTERVENTION TO REDUCE HIV/STD RISK
$721,385Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2002 · MH
Long-term Effects of Health and Development Interventions in Rural Bangladesh
$721,383Jane A Menken · University Of Colorado · R01 · FY2011 · AG
Biology of the Lung: A Multidisciplinary Program
$721,350David M Center · Boston University Medical Campus · T32 · FY2014 · HL
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
$721,322Gulin Oz · University Of Minnesota · R01 · FY2021 · NS
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$721,321Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2025 · AI
Functional genomic analysis of the CD8 T cell response to HIV vaccines in
$721,315William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2013 · AI
Childhood infection and prevention of obesity
$721,280Julie Parsonnet · Stanford University · R01 · FY2011 · HD
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
$721,276Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2020 · CA
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
$721,274Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2017 · CA
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
$721,272Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2018 · CA
Development of a Self Inactivating, Highly Effective TB Vaccine
$721,271Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI